Alternative Complement Pathway Deregulation Is Correlated with Dengue Severity

• Eduardo J. M. Nascimento,

  Affiliation Division of Infectious Diseases, Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Ana M. Silva,

  Affiliation Virology and Experimental Therapy Laboratory, Aggeu Magalhães Research Center-CPqAM/FIOCRUZ, Recife, Pernambuco, Brazil

  ⨯
• Marli T. Cordeiro,

  Affiliation Virology and Experimental Therapy Laboratory, Aggeu Magalhães Research Center-CPqAM/FIOCRUZ, Recife, Pernambuco, Brazil

  ⨯
• Carlos A. Brito,

  Affiliation Virology and Experimental Therapy Laboratory, Aggeu Magalhães Research Center-CPqAM/FIOCRUZ, Recife, Pernambuco, Brazil

  ⨯
• Laura H. V. G. Gil,

  Affiliation Virology and Experimental Therapy Laboratory, Aggeu Magalhães Research Center-CPqAM/FIOCRUZ, Recife, Pernambuco, Brazil

  ⨯
• Ulisses Braga-Neto,

  Affiliation Department of Electrical and Computer Engineering, Texas A&M University, College Station, Texas, United States of America

  ⨯
• Ernesto T. A. Marques

  * E-mail: emarques@jhmi.edu

  Affiliations Division of Infectious Diseases, Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America, Virology and Experimental Therapy Laboratory, Aggeu Magalhães Research Center-CPqAM/FIOCRUZ, Recife, Pernambuco, Brazil, Department of Pharmacology and Molecular Sciences, The Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America

  ⨯